Brief: Immuron Approves Imm-529 CGMP Manufacturing And To Proceed With FDA Pre-Ind Submission
June 22 (Reuters) - Immuron Ltd IMC.AX :
* BOARD APPROVES IMM-529 CGMP MANUFACTURING AND TO PROCEED
WITH
FDA PRE-IND SUBMISSION
Source text for Eikon: ID:nASX3qNKs2
Further company coverage: IMC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immuron
See all newsBrief: Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
Australia's Immuron hits near 1.5-month high on distribution deal in US
Brief: Immuron Executes Exclusive Distribution Agreement For Proibs In The United States
Brief: Immuron Reports FY26 Preliminary Results
Brief: Immuron Posts FY Revenue From Ordinary Activities Of A$7.71 Million